SEC Form 4 · accession 0001209191-15-032295
CORCEPT THERAPEUTICS INC · CORT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James N Wilson
Director
Period of report
Apr 1, 2015
Accepted (ET)
Apr 3, 2015 · 4:27 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001088856
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stock | Apr 1, 2015 | M | 10,000 | $1.51 | A | 1,711,396 | D | |
| Common StockF1 | Apr 1, 2015 | S | 10,000 | $5.5998 | D | 1,701,396 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock optionF2 | $1.51 | Apr 1, 2015 | M | 10,000 | D | — | May 18, 2017 | Common stock | 10,000 | 240,000 | D |
Explanation of responses
- F1Represents the weighted average sale price for the entire number of shares sold. The sale prices range from $5.55 to $5.70 per share.
- F2Fully exercisable